COMMUNIQUÉS West-GlobeNewswire

INP and Fight For Life Club Foundation Make History: Two Pediatric Living Donor Liver Transplants in One Week

03/05/2025 - 03:26

Dallas, Texas, May 02, 2025 (GLOBE NEWSWIRE) -- In a historic medical achievement, the National Institute of Pediatrics (INP), in collaboration with the Fight For Life Club Foundation , has successfully performed two [...]

Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08

03/05/2025 - 03:30

PURCHASE, N.Y., May 02, 2025 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in virtual care, today announced that it issued inducement awards to five new employees. Effective April 30, 2025, in [...]

IBA lance myQA Blue Phantom³ pour l'assurance qualité en radiothérapie

02/05/2025 - 20:15

L'offre de nivellement automatique la plus rapide du marché Intégration aisée avec tous les accélérateurs linéaires Louvain-la-Neuve, Belgique, le 2 mai 2025 – IBA (Ion Beam Applications S.A., EURONEXT), le leader [...]

IBA launches myQA Blue Phantom³ for radiation therapy quality assurance

02/05/2025 - 20:15

Fastest automatic levelling offering on the market Seamless integration with all linear accelerators Louvain-la-Neuve, Belgium, 2 May 2025 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle [...]

Just Blood Uncovers New Blood Testing Technology

02/05/2025 - 21:08

Lab Expert Ryan El-Hosseiny Shut Down Times Square to Set the Record Straight NEW YORK, May 02, 2025 (GLOBE NEWSWIRE) -- In a much-anticipated live demonstration on April 30, 2025, Laboratory expert and entrepreneur [...]

Pacific Health Care Organization, Inc. Reports its First Quarter 2025 Financial Results

02/05/2025 - 21:18

Irvine, CA, May 02, 2025 (GLOBE NEWSWIRE) -- Pacific Health Care Organization, Inc., (the “Company”) (OTCQB: PFHO) today filed with the Securities and Exchange Commission (the “SEC”) its quarterly report on Form 10-Q [...]

Tevogen to Share Direct Registration System (DRS) Process Details Following Increased Shareholder Interest

02/05/2025 - 21:45

WARREN, N.J., May 02, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN ) today announced that, following the Company’s recent press release highlighting the Direct Registration [...]

Spectral AI Schedules 2025 First Quarter Financial Results and Conference Call

02/05/2025 - 22:00

DALLAS, May 02, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ: MDAI) (“Spectral AI” or the “Company”), a leading developer of the AI-driven DeepView ® System, which uses multi-spectral imaging and AI algorithms to [...]

Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

02/05/2025 - 22:00

WESTLAKE VILLAGE, Calif., May 02, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, [...]

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

02/05/2025 - 22:01

NAARDEN, the Netherlands and MIAMI, May 02, 2025 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, [...]

Adverum Biotechnologies Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

02/05/2025 - 22:01

REDWOOD CITY, Calif., May 02, 2025 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM) today announced that the Compensation Committee of Adverum’s Board of Directors granted inducement awards consisting of [...]

Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

02/05/2025 - 22:01

SAN DIEGO, May 02, 2025 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)- [...]

Iovance Biotherapeutics to Host First Quarter 2025 Financial Results and Corporate Updates Webcast on Thursday, May 8, 2025

02/05/2025 - 22:01

SAN CARLOS, Calif., May 02, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte [...]

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

02/05/2025 - 22:05

NEW YORK, May 02, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX ), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that on May 1, 2025 the Company [...]

NurExone Expands European Engagement with Investor Events in Germany and Switzerland

02/05/2025 - 22:05

TORONTO and HAIFA, Israel, May 02, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“ NurExone ” or the “ Company ”), a preclinical-stage biotechnology company pioneering exosome- [...]

Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)

02/05/2025 - 22:05

FOSTER CITY, Calif., May 02, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product [...]

Jushi Holdings Inc. Updates Call Time to 4:00 p.m. Eastern Time to Report First Quarter 2025 Financial Results on May 8, 2025

02/05/2025 - 22:05

BOCA RATON, Fla., May 02, 2025 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCQX: JUSHF) , a vertically integrated, multi-state cannabis operator, announced that it expects to report [...]

Bon Natural Life Limited Announces Receipt of Nasdaq Delisting Notifications

02/05/2025 - 22:10

XI’AN, China, May 02, 2025 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) (“BON” or the “Company”), one of the leading bio-ingredient solutions providers in the natural, health and personal care industries, [...]

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

02/05/2025 - 22:30

SOUTH SAN FRANCISCO Calif. and SAN DIEGO, May 02, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of [...]